Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients (vol 51, pg 594, 2018)

被引：0
|
作者：
Dhaese, Sofie A. M. [1 ]
Roberts, Jason A. [2 ,3 ,4 ]
Carlier, Mieke [5 ]
Verstraete, Alain G. [5 ,6 ]
Stove, Veronique [5 ,6 ]
DeWaele, Jan J. [1 ]
机构：
[1] Ghent Univ Hosp, Intens Care, C Heymanslaan 10, B-9000 Ghent, Belgium
[2] Univ Queensland, Fac Med, Brisbane, Qld, Australia
[3] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia
[4] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[5] Ghent Univ Hosp, Lab Med, Ghent, Belgium
[6] Univ Ghent, Clin Chem Microbiol & Immunol, Ghent, Belgium
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2019年 / 54卷 / 02期
关键词：
D O I：
10.1016/j.ijantimicag.2019.07.007
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：271 / 271
页数：1
相关论文
共 50 条
  • [1] Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients (vol 51, pg 594, 2018)
    Dhaese, Sofie A. M.
    Roberts, Jason A.
    Carlier, Mieke
    Verstraete, Alain G.
    Stove, Veronique
    De Waele, Jan J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (03) : 380 - 380
  • [2] Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients
    Dhaese, Sofie A. M.
    Roberts, Jason A.
    Carlier, Mieke
    Verstraete, Alain G.
    Stove, Veronique
    DeWaele, Jan J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (04) : 594 - 600
  • [3] Population Pharmacokinetics of Piperacillin following Continuous Infusion in Critically Ill Patients and Impact of Renal Function on Target Attainment
    Klastrup, Vibeke
    Thorsted, Anders
    Storgaard, Merete
    Christensen, Steffen
    Friberg, Lena E.
    Obrink-Hansen, Kristina
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (07)
  • [4] Population pharmacokinetics of ceftriaxone administered as continuous or intermittent infusion in critically ill patients
    Leegwater, E.
    Kraaijenbrink, B. V. C.
    Moes, D. J. A. R.
    Purmer, I. M.
    Wilms, E. B.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (06) : 1554 - 1558
  • [5] Neurotoxic Concentration of Piperacillin during Continuous Infusion in Critically Ill Patients
    Quinton, Marie-Charlotte
    Bodeau, Sandra
    Kontar, Loay
    Zerbib, Yoann
    Maizel, Julien
    Slama, Michel
    Masmoudi, Kamel
    Lemaire-Hurtel, Anne-Sophie
    Bennis, Youssef
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (09)
  • [6] Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion
    Dhaese, S. A. M.
    Colin, P.
    Willems, H.
    Heffernan, A.
    Gadeyne, B.
    Van Vooren, S.
    Depuydt, P.
    Hoste, E.
    Stove, V
    Verstraete, A. G.
    Lipman, J.
    Roberts, J. A.
    De Waele, J. J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (06) : 741 - 749
  • [7] Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children
    Nichols, Kristen
    Chung, Eun Kyoung
    Knoderer, Chad A.
    Buenger, Lauren E.
    Healy, Daniel P.
    Dees, Jennifer
    Crumby, Ashley S.
    Kays, Michael B.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 522 - 531
  • [8] Continuous infusion of piperacillin and therapeutic drug monitoring for treatment of critically ill patients
    Koeberer, A.
    Frey, O. R.
    Papadimas, N.
    Fuchs, T.
    Roehr, A.
    Brinkmann, A.
    [J]. INFECTION, 2013, 41 : S54 - S54
  • [9] Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients
    El-Haffaf, Ibrahim
    Guilhaumou, Romain
    Velly, Lionel
    Marsot, Amelie
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (06) : 895 - 906
  • [10] Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients
    Ibrahim El-Haffaf
    Romain Guilhaumou
    Lionel Velly
    Amélie Marsot
    [J]. Clinical Pharmacokinetics, 2022, 61 : 895 - 906
12345